# Utilization of Target Ranges to Treat Parkinson's Disease With the PKG

> **NCT03984305** · NA · TERMINATED · sponsor: **Global Kinetics Corporation** · enrollment: 41 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DEVICE:** Personal KinetiGraph® (PKG®) Watch
- **DEVICE:** Personal KinetiGraph® (PKG®) Report

## Key facts

- **NCT ID:** NCT03984305
- **Lead sponsor:** Global Kinetics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-10-15
- **Primary completion:** 2020-10-16
- **Final completion:** 2020-10-16
- **Target enrollment:** 41 (ACTUAL)
- **Why stopped:** Terminated due to significant protocol updates that resulted in initiating a new study
- **Last updated:** 2022-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03984305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03984305, "Utilization of Target Ranges to Treat Parkinson's Disease With the PKG". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03984305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*